Clinical trial
Lactate and Glycerol Contribution to Gluconeogenesis
Opening soon · Not applicable · 0 countries · Registry ID NCT06955130
What this study is about
A major cause of increased blood glucose levels in type 2 diabetes (T2D) is increased hepatic gluconeogenesis (GNG), as the liver converts various substrates into glucose. Two of these substrates include glycerol, a molecule from fat, and lactate, a molecule that circulates in the blood. Our previously collected data suggest that glycerol's role in this process has been underestimated, so the investigators will directly compare the carbon contribution of glycerol and lactate to new glucose production under fasting conditions in patients with and without T2D. The investigators will also assess how glucagon, a hormone that raises blood glucose levels, impacts the conversion of glycerol and lactate to glucose. Enrolled participants will undergo three separate isotope tracer infusions with serial blood collections for liquid chromatography-mass spectrometry analysis. This research could identify new therapeutic drug targets that can lower blood glucose levels more directly and effectively.
Basic eligibility
Full registry criteria
Treatments and study arms
Glycerol
Subjects will receive an infusion of glycerol and glucagon.
Lactate
Subjects will receive an infusion of lactate and glucagon.
Glucose
Subjects will receive an infusion of glucose and glucagon.
Primary outcomes
Net carbon flux from glycerol and lactate to glucose will be measured using LC-MS of plasma glucose via 13C-enrichment after infusion of various metabolic tracers
Study locations
0 locations were listed when this page was built. The first 40 are shown.